3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
34
Carcinoma, Non-Small-Cell Lung
22
Carcinoma, Renal Cell
20
Neoplasm Metastasis
13
Carcinoma, Hepatocellular
10
Brain Neoplasms
8
Lung Neoplasms
7
Skin Neoplasms
6
Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Kidney Neoplasms
5
Clear-cell metastatic renal cell carcinoma
5
Carcinoma, Transitional Cell
5
Uveal Melanoma
4
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Glioblastoma
4
Carcinoma, Basal Cell
4
Carcinoma
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Sarcoma
3
Recurrence
3
Mesothelioma
3
Liver Neoplasms
3
Leukemia, Myeloid, Acute
3
Histiocytoma, Malignant Fibrous
3
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Cisplatin
4
trastuzumab deruxtecan
3
Platinum
3
Docetaxel
3
Carboplatin
3
Biopsy
3
pembrolizumab
2
entrectinib
2
darolutamide
2
Trastuzumab
2
Radiotherapy, Intensity-Modulated
2
Leuprolide
2
Goserelin
2
Ado-Trastuzumab Emtansine
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
trastuzumab biosimilar HLX02
1
sacituzumab govitecan
1
pyrotinib
1
pertuzumab
1
luprolide acetate gel depot
1
larotrectinib
1
enfortumab vedotin
1
dehydroftorafur
1
ceralasertib
1
camrelizumab
1
bicalutamide
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Ipilimumab
×
90 days
×
Clear all
No trials found.